Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide

M. Lunney, AK. Bello, A. Levin, H. Tam-Tham, C. Thomas, MA. Osman, F. Ye, E. Bellorin-Font, M. Benghanem Gharbi, M. Ghnaimat, H. Htay, Y. Cho, V. Jha, S. Ossareh, E. Rondeau, L. Sola, I. Tchokhonelidze, V. Tesar, K. Tungsanga, RT. Kazancioglu,...

. 2020 ; 16 (1) : 79-87. [pub] 20201215

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK Free Medical Journals from 2006 to 1 year ago
PubMed Central from 2008 to 1 year ago
Europe PubMed Central from 2008 to 1 year ago
Open Access Digital Library from 2006-01-01

BACKGROUND AND OBJECTIVES: People with kidney failure typically receive KRT in the form of dialysis or transplantation. However, studies have suggested that not all patients with kidney failure are best suited for KRT. Additionally, KRT is costly and not always accessible in resource-restricted settings. Conservative kidney management is an alternate kidney failure therapy that focuses on symptom management, psychologic health, spiritual care, and family and social support. Despite the importance of conservative kidney management in kidney failure care, several barriers exist that affect its uptake and quality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The Global Kidney Health Atlas is an ongoing initiative of the International Society of Nephrology that aims to monitor and evaluate the status of global kidney care worldwide. This study reports on findings from the 2018 Global Kidney Health Atlas survey, specifically addressing the availability, accessibility, and quality of conservative kidney management. RESULTS: Respondents from 160 countries completed the survey, and 154 answered questions pertaining to conservative kidney management. Of these, 124 (81%) stated that conservative kidney management was available. Accessibility was low worldwide, particularly in low-income countries. Less than half of countries utilized multidisciplinary teams (46%); utilized shared decision making (32%); or provided psychologic, cultural, or spiritual support (36%). One-quarter provided relevant health care providers with training on conservative kidney management delivery. CONCLUSIONS: Overall, conservative kidney management is available in most countries; however, it is not optimally accessible or of the highest quality.

Australasian Kidney Trials Network University of Queensland Brisbane Queensland Australia

Bhumirajanagarindra Kidney Institute Bangkok Thailand

Centre for Transplantation and Renal Research Westmead Institute for Medical Research University of Sydney Sydney New South Wales Australia

Department of Community Health Sciences University of Calgary Calgary Alberta Canada

Department of Epidemiology and Biostatistics School of Public Health Imperial College London United Kingdom

Department of Family Medicine University of Ottawa Ottawa Ontario Canada

Department of Internal Diseases Clinical Pharmacology and Nephrology North Western State Medical University named after 1 1 Mechnikov St Petersburg Russia

Department of Medicine Faculty of Medicine King Chulalongkorn Memorial Hospital Chulalongkorn University Bangkok Thailand

Department of Medicine The University of Hong Kong Queen Mary Hospital Hong Kong Special Administrative Region China

Department of Medicine University of Calgary Calgary Alberta Canada

Department of Nephrology and Dialysis Pavlov 1st St Petersburg State Medical University St Petersburg Russia

Department of Nephrology General University Hospital Charles University Prague Czech Republic

Department of Renal Medicine Singapore General Hospital Singapore

Department of Renal Medicine St George Hospital and University of New South Wales Sydney New South Wales Australia

Dialysis Unit Centro de Asistencia del Sindicato Médico del Uruguay Institución de Asistencia Medica Privada de Profesionales Montevideo Uruguay

Division of Nephology and Hypertension Saint Louis University St Louis Missouri

Division of Nephrology and Hypertension University of Cape Town Cape Town South Africa

Division of Nephrology and Immunology Department of Medicine University of Alberta Edmonton Alberta Canada

Division of Nephrology Bezmialem Vakif University Istanbul Turkey

Division of Nephrology Department of Medicine Hasheminejad Kidney Center Iran University of Medical Sciences Tehran Iran

Division of Nephrology Department of Medicine University of British Columbia Vancouver British Columbia Canada

Division of Nephrology Faculty of Medicine Chulalongkorn University Bangkok Thailand

European Renal Association European Dialysis and Transplant Association Registry Department of Medical Informatics Academic Medical Center Amsterdam Public Health Research Institute University of Amsterdam Amsterdam The Netherlands

George Institute for Global Health University of New South Wales New Delhi India

Imperial College Renal and Transplant Centre Hammersmith Hospital London England

Intensive Care Nephrology and Transplantation Department Hopital Tenon Assistance Publique Hopitaux de Paris Paris France

Intensive Care Nephrology and Transplantation Department Hopital Tenon Assistance Publique Hopitaux de Paris Paris France and Sorbonne Université Paris France

Key Lab of Chronic Kidney Disease Prevention and Treatment Ministry of Education of China Beijing China

Key Lab of Renal Disease Ministry of Health of China Beijing China

Kidney and Hypertension Research Unit University of Cape Town Cape Town South Africa

Kidney Research Center Department of Nephrology Chang Gung Memorial Hospital Chang Gung University College of Medicine Taoyuan Taiwan

Kidney Research Center Department of Nephrology Chang Gung Memorial Hospital Linkou Taiwan

Metro South Integrated Nephrology and Transplant Services Princess Alexandra Hospital Brisbane Queensland Australia

Nephrology Development Clinical Center Tbilisi State Medical University Tbilisi Georgia

Nephrology Division Department of Internal Medicine The Specialty Hospital Amman Jordan

Pan American Health Organization World Health Organization's Collaborating Centre in Prevention and Control of Chronic Kidney Disease Cumming School of Medicine University of Calgary Calgary Alberta Canada

Peking Tsinghua Center for Life Sciences Beijing China

Prasanna School of Public Health Manipal Academy of Higher Education Manipal Karnataka India

Renal Division Department of Medicine Peking University 1st Hospital Beijing China

Richard Bright Renal Unit Southmead Hospital North Bristol National Health Service Trust Bristol United Kingdom

Translational Research Institute Brisbane Queensland Australia

UK Renal Registry Learning and Research Southmead Hospital Bristol United Kingdom and Population Health Sciences University of Bristol Bristol United Kingdom

Urinary Tract Diseases Department Faculty of Medicine and Pharmacy of Casablanca University Hassan 2 of Casablanca Casablanca Morocco

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004751
003      
CZ-PrNML
005      
20220127145024.0
007      
ta
008      
220113s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.2215/CJN.09070620 $2 doi
035    __
$a (PubMed)33323461
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Lunney, Meaghan $u Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
245    10
$a Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide / $c M. Lunney, AK. Bello, A. Levin, H. Tam-Tham, C. Thomas, MA. Osman, F. Ye, E. Bellorin-Font, M. Benghanem Gharbi, M. Ghnaimat, H. Htay, Y. Cho, V. Jha, S. Ossareh, E. Rondeau, L. Sola, I. Tchokhonelidze, V. Tesar, K. Tungsanga, RT. Kazancioglu, AY. Wang, CW. Yang, A. Zemchenkov, MH. Zhao, KJ. Jager, KK. Jindal, IG. Okpechi, EA. Brown, M. Brown, M. Tonelli, DC. Harris, DW. Johnson, FJ. Caskey, SN. Davison
520    9_
$a BACKGROUND AND OBJECTIVES: People with kidney failure typically receive KRT in the form of dialysis or transplantation. However, studies have suggested that not all patients with kidney failure are best suited for KRT. Additionally, KRT is costly and not always accessible in resource-restricted settings. Conservative kidney management is an alternate kidney failure therapy that focuses on symptom management, psychologic health, spiritual care, and family and social support. Despite the importance of conservative kidney management in kidney failure care, several barriers exist that affect its uptake and quality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The Global Kidney Health Atlas is an ongoing initiative of the International Society of Nephrology that aims to monitor and evaluate the status of global kidney care worldwide. This study reports on findings from the 2018 Global Kidney Health Atlas survey, specifically addressing the availability, accessibility, and quality of conservative kidney management. RESULTS: Respondents from 160 countries completed the survey, and 154 answered questions pertaining to conservative kidney management. Of these, 124 (81%) stated that conservative kidney management was available. Accessibility was low worldwide, particularly in low-income countries. Less than half of countries utilized multidisciplinary teams (46%); utilized shared decision making (32%); or provided psychologic, cultural, or spiritual support (36%). One-quarter provided relevant health care providers with training on conservative kidney management delivery. CONCLUSIONS: Overall, conservative kidney management is available in most countries; however, it is not optimally accessible or of the highest quality.
650    12
$a konzervativní terapie $x normy $7 D000072700
650    _2
$a sdílené rozhodování $7 D000080536
650    _2
$a vyspělé země $x statistika a číselné údaje $7 D019049
650    _2
$a rozvojové země $x statistika a číselné údaje $7 D003906
650    _2
$a dostupnost zdravotnických služeb $x statistika a číselné údaje $7 D006297
650    _2
$a lidé $7 D006801
650    _2
$a internacionalita $7 D038622
650    _2
$a chronické selhání ledvin $x terapie $7 D007676
650    _2
$a týmová péče o pacienty $x statistika a číselné údaje $7 D010348
650    12
$a kvalita zdravotní péče $7 D011787
650    _2
$a náboženství $7 D012067
650    _2
$a sociální opora $7 D012944
650    _2
$a průzkumy a dotazníky $7 D011795
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bello, Aminu K $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Levin, Adeera $u Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
700    1_
$a Tam-Tham, Helen $u Department of Medicine, University of Calgary, Calgary, Alberta, Canada
700    1_
$a Thomas, Chandra $u Department of Medicine, University of Calgary, Calgary, Alberta, Canada
700    1_
$a Osman, Mohamed A $u Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada
700    1_
$a Ye, Feng $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Bellorin-Font, Ezequiel $u Division of Nephology and Hypertension, Saint Louis University, St. Louis, Missouri
700    1_
$a Benghanem Gharbi, Mohammed $u Urinary Tract Diseases Department, Faculty of Medicine and Pharmacy of Casablanca, University Hassan II of Casablanca, Casablanca, Morocco
700    1_
$a Ghnaimat, Mohammad $u Nephrology Division, Department of Internal Medicine, The Specialty Hospital, Amman, Jordan
700    1_
$a Htay, Htay $u Department of Renal Medicine, Singapore General Hospital, Singapore
700    1_
$a Cho, Yeoungjee $u Australasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia sara.davison@ualberta.ca $u Translational Research Institute, Brisbane, Queensland, Australia $u Metro South Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia
700    1_
$a Jha, Vivekanand $u George Institute for Global Health, University of New South Wales, New Delhi, India $u Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom $u Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka, India
700    1_
$a Ossareh, Shahrzad $u Division of Nephrology, Department of Medicine, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran
700    1_
$a Rondeau, Eric $u Intensive Care Nephrology and Transplantation Department, Hopital Tenon, Assistance Publique-Hopitaux de Paris, Paris, France $u Intensive Care Nephrology and Transplantation Department, Hopital Tenon, Assistance Publique-Hopitaux de Paris, Paris, France and Sorbonne Université, Paris, France
700    1_
$a Sola, Laura $u Dialysis Unit, Centro de Asistencia del Sindicato Médico del Uruguay - Institución de Asistencia Medica Privada de Profesionales (CASMU-IAMPP), Montevideo, Uruguay
700    1_
$a Tchokhonelidze, Irma $u Nephrology Development Clinical Center, Tbilisi State Medical University, Tbilisi, Georgia
700    1_
$a Tesar, Vladimir $u Department of Nephrology, General University Hospital, Charles University, Prague, Czech Republic
700    1_
$a Tungsanga, Kriang $u Department of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand $u Division of Nephrology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Bhumirajanagarindra Kidney Institute, Bangkok, Thailand
700    1_
$a Kazancioglu, Rumeyza Turan $u Division of Nephrology, Bezmialem Vakif University, Istanbul, Turkey
700    1_
$a Wang, Angela Yee-Moon $u Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong Special Administrative Region, China
700    1_
$a Yang, Chih-Wei $u Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan $u Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan
700    1_
$a Zemchenkov, Alexander $u Department of Internal Diseases, Clinical Pharmacology, and Nephrology, North-Western State Medical University named after I. I. Mechnikov, St. Petersburg, Russia $u Department of Nephrology and Dialysis, Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia
700    1_
$a Zhao, Ming-Hui $u Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China $u Key Lab of Renal Disease, Ministry of Health of China, Beijing, China $u Key Lab of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing, China $u Peking-Tsinghua Center for Life Sciences, Beijing, China
700    1_
$a Jager, Kitty J $u European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, The Netherlands
700    1_
$a Jindal, Kailash K $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Okpechi, Ikechi G $u Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa $u Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa
700    1_
$a Brown, Edwina A $u Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, England
700    1_
$a Brown, Mark $u Department of Renal Medicine, St George Hospital and University of New South Wales, Sydney, New South Wales, Australia
700    1_
$a Tonelli, Marcello $u Department of Medicine, University of Calgary, Calgary, Alberta, Canada $u Pan-American Health Organization/World Health Organization's Collaborating Centre in Prevention and Control of Chronic Kidney Disease, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
700    1_
$a Harris, David C $u Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia
700    1_
$a Johnson, David W $u Australasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia $u Translational Research Institute, Brisbane, Queensland, Australia $u Metro South Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia
700    1_
$a Caskey, Fergus J $u UK Renal Registry, Learning and Research, Southmead Hospital, Bristol, United Kingdom and Population Health Sciences, University of Bristol, Bristol, United Kingdom $u Richard Bright Renal Unit, Southmead Hospital, North Bristol National Health Service Trust, Bristol, United Kingdom
700    1_
$a Davison, Sara N $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada sara.davison@ualberta.ca
773    0_
$w MED00156165 $t Clinical journal of the American Society of Nephrology : CJASN $x 1555-905X $g Roč. 16, č. 1 (2020), s. 79-87
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33323461 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145021 $b ABA008
999    __
$a ok $b bmc $g 1752051 $s 1155900
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 16 $c 1 $d 79-87 $e 20201215 $i 1555-905X $m Clinical journal of the American Society of Nephrology $n Clin J Am Soc Nephrol $x MED00156165
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...